藍帆醫療(002382.SZ):與齊翔騰達就羧基丁腈膠乳產品供貨事宜達成一致意見並簽署戰略合作框架協議
格隆匯 11 月 30日丨藍帆醫療(002382.SZ)公佈,2020年,新冠肺炎疫情在全球漫延,全球對丁腈手套等的需求量激增,公司積極擴大產能,隨着公司“第三期年產20億支健康防護(新型手套)項目”的全面建成投產、“300億支/年健康防護(丁腈)手套項目”一期的籌備建設,公司對丁腈手套的主要原材料丁腈膠乳的需求量增幅較大。
淄博齊翔騰達化工股份有限公司(“齊翔騰達”)是國內碳四深加工領域龍頭,中國化工五百強企業,擁有世界最大的甲乙酮和順杆裝置,主營業務為各類化工及新材料的生產及銷售。作為公司的優質供應商之一,一直與公司保持着良好的合作關係。
近日,齊翔騰達投資建設的20萬噸/年丁腈膠乳項目一期(10萬噸/年)生產線已建設完成並產出高質量的丁腈膠乳,無論是從產品質量還是產量上均能夠滿足公司的需求。鑑於此,雙方本着互利共贏的原則就羧基丁腈膠乳產品供貨事宜達成一致意見並簽署了《戰略合作框架協議》。
自2020年12月1日至2021年12月31日,齊翔騰達銷售給公司羧基丁腈膠乳不低於30000噸。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.